leisure time -WSS

leisure time

author：leisure time 2025-09-30 17:17:19 - browse：8312

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： How dance can help health care workers heal from trauma

WSS

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

AI can’t replace a physician’s gut feeling

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

The kidney, in all its complexity, is captured in a new atlas

WHO calls for emergency meeting on new China virus, as cases spread

Google and Epic fight stronger regulation of AI in health care

focus

leisure time

entertainment

Medical leaders decry Supreme Court decision on affirmative action

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

'Reaching a detente': STAT's Helen Branswell on covering Covid

Apple is now the first public company to be valued at $3 trillion

Why some people catch Covid but never get sick

Bright Health sells Medicare Advantage business to Molina

Why hospitals are withdrawing from US News rankings

Drug repurposing or repositioning? The language matters

Biden tests positive for Covid

knowledge

As digital health tech proliferates, a new institute aims to cut through hype

How dance can help health care workers heal from trauma

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Biden tests positive for Covid

TikTok cracks down on users posting about weight loss drugs

Custom gene therapy hints at new path for rare disease treatments

knowledge

hotspot

focus

knowledge